Northland Securities Predicts IMSR FY2025 Earnings

Key Points

• Northland Securities reiterated an Outperform rating and a $15.00 price target on HCM II Acquisition (IMSR) while forecasting FY2025 EPS of ($0.42) and continued losses through FY2026–FY2027 (FY2027 EPS ~($0.68)).
• Its research provided detailed quarterly EPS estimates for 2026–2027 (generally ~($0.10)–($0.17) per quarter), giving investors updated modeling inputs to re-price the stock.
• Other analysts are mixed—Cantor Fitzgerald initiated coverage with an "overweight" and $12 target while Weiss Ratings and Wall Street Zen have sell calls—leaving the MarketBeat consensus at a "Hold" rating and an average target of $13.50, versus the stock trading around $9.11 (12‑month range $5.95–$31.50).

HCM II Acquisition Corp. (NASDAQ:IMSR - Free Report) - Investment analysts at Northland Securities issued their FY2025 earnings estimates for HCM II Acquisition in a research report issued on Thursday, January 29th. Northland Securities analyst J. Grampp expects that the company will post earnings per share of ($0.42) for the year. Northland Securities currently has a "Outperform" rating and a $15.00 target price on the stock. Northland Securities also issued estimates for HCM II Acquisition's Q1 2026 earnings at ($0.10) EPS, Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.13) EPS, Q4 2026 earnings at ($0.14) EPS, FY2026 earnings at ($0.49) EPS, Q1 2027 earnings at ($0.17) EPS, Q2 2027 earnings at ($0.17) EPS, Q3 2027 earnings at ($0.17) EPS, Q4 2027 earnings at ($0.17) EPS and FY2027 earnings at ($0.68) EPS.

IMSR has been the topic of several other research reports. Cantor Fitzgerald initiated coverage on HCM II Acquisition in a research report on Friday, December 19th. They issued an "overweight" rating and a $12.00 target price on the stock. Weiss Ratings restated a "sell (d)" rating on shares of HCM II Acquisition in a report on Wednesday, December 24th. Finally, Wall Street Zen lowered shares of HCM II Acquisition from a "hold" rating to a "sell" rating in a report on Monday, December 22nd. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $13.50.

HCM II Acquisition Stock Down 1.4%

Shares of HCM II Acquisition stock opened at $9.11 on Monday. HCM II Acquisition has a twelve month low of $5.95 and a twelve month high of $31.50.

Trending Headlines about HCM II Acquisition

Here are the key news stories impacting HCM II Acquisition this week:

• Positive Sentiment: Northland Securities reiterated an Outperform rating and a $15.00 price target on IMSR, implying substantial upside from the current trade level if the company or market sentiment improves. MarketBeat: IMSR Analyst Note
• Neutral Sentiment: The research note provided a full set of quarterly and annual EPS forecasts (detailed estimates for Q1–Q4 2026, Q1–Q4 2027 and FY2025–FY2027), giving investors updated modeling inputs to re-price the stock. Use these to update valuation scenarios. MarketBeat: IMSR Analyst Estimates
• Negative Sentiment: Northland’s forecasts show persistent losses: FY2026 EPS ~($0.49) and FY2027 EPS ~($0.68), with quarterly EPS generally in the (~$0.10)–($0.17) range — a trajectory that can weigh on valuation and help explain the stock’s downward move. MarketBeat: IMSR Loss Estimates

About HCM II Acquisition

Terrestrial Energy Inc produces carbon free nuclear energy in North Carolina and internationally. The company was founded in 2013 and is headquartered in Charlotte, North Carolina.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.